(2R,3R)-2-(2,2-Dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl palmitate
| Title | Journal |
|---|---|
| FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. | Chemico-biological interactions 20130905 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Characterization of chloramphenicol palmitate drug polymorphs by Raman mapping with multivariate image segmentation using a spatial directed agglomeration clustering method. | Analytical chemistry 20060901 |
| Effect of a change in crystal polymorph on the degree of adhesion between micronized drug particles and large homogenous carrier particles during an interactive mixing process. | Pharmaceutical development and technology 20041101 |
| Arthroderma benhamiae infection in a rabbit. | The Journal of veterinary medical science 20010801 |
| Concordance for drug-induced aplastic anemia in identical twins. | The New England journal of medicine 19690703 |